{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T18:42:38Z","timestamp":1740163358000,"version":"3.37.3"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T00:00:00Z","timestamp":1658966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T00:00:00Z","timestamp":1658966400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1007\/s13555-022-00781-3","type":"journal-article","created":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T12:58:08Z","timestamp":1659013088000},"page":"2173-2180","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Reassurance Techniques Do Not Significantly Impact Confidence in Biosimilars for Psoriasis: A Survey of a Convenience Sample of Individuals with Self-Identified Psoriasis"],"prefix":"10.1007","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2769-3156","authenticated-orcid":false,"given":"Matthew L.","family":"Hrin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremy K.","family":"Bray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven R.","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,7,28]]},"reference":[{"key":"781_CR1","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s13555-018-0230-9","volume":"8","author":"JM Carrascosa","year":"2018","unstructured":"Carrascosa JM, Jacobs I, Petersel D, Strohal R. Biosimilar drugs for psoriasis: principles, present, and near future. Dermatol Ther (Heidelb). 2018;8:173\u201394.","journal-title":"Dermatol Ther (Heidelb)"},{"key":"781_CR2","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1002\/acr2.1007","volume":"1","author":"J Chau","year":"2019","unstructured":"Chau J, Delate T, Ota T, Bhardwaja B. Patient perspectives on switching from infliximab to infliximab-dyyb in patients with rheumatologic diseases in the United States. ACR Open Rheumatol. 2019;1:52\u20137.","journal-title":"ACR Open Rheumatol"},{"key":"781_CR3","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.3389\/fphar.2019.01372","volume":"10","author":"L Colloca","year":"2019","unstructured":"Colloca L, Panaccione R, Murphy TK. The clinical implications of nocebo effects for biosimilar therapy. Front Pharmacol. 2019;10:1372.","journal-title":"Front Pharmacol"},{"key":"781_CR4","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1177\/1715163519879411","volume":"152","author":"N Sosulski","year":"2019","unstructured":"Sosulski N. A brief overview of biosimilars and factors limiting their uptake. Can Pharm J (Ott). 2019;152:364\u20136.","journal-title":"Can Pharm J (Ott)"},{"key":"781_CR5","doi-asserted-by":"publisher","first-page":"937","DOI":"10.2147\/PPA.S104891","volume":"10","author":"I Jacobs","year":"2016","unstructured":"Jacobs I, Singh E, Sewell KL, Al-Sabbagh A, Shane LG. Patient attitudes and understanding about biosimilars: an international cross-sectional survey. Patient Prefer Adherence. 2016;10:937\u201348.","journal-title":"Patient Prefer Adherence"},{"key":"781_CR6","doi-asserted-by":"publisher","first-page":"496","DOI":"10.20344\/amp.10127","volume":"31","author":"A Azevedo","year":"2018","unstructured":"Azevedo A, Bettencourt A, Selores M, Torres T. Biosimilar agents for psoriasis treatment: the perspective of Portuguese patients. Acta Med Port. 2018;31:496\u2013500.","journal-title":"Acta Med Port"},{"key":"781_CR7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1177\/1745691610393980","volume":"6","author":"M Buhrmester","year":"2011","unstructured":"Buhrmester M, Kwang T, Gosling SD. Amazon\u2019s Mechanical Turk: a new source of inexpensive, yet high-quality, data? Perspect Psychol Sci. 2011;6:3\u20135.","journal-title":"Perspect Psychol Sci"},{"key":"781_CR8","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1177\/1203475419871050","volume":"24","author":"MC Johnson","year":"2020","unstructured":"Johnson MC, Pona A, Adler-Neal AL, Kesty C, Cline A, Feldman SR. Assessing the effect of clinical trial evidence and anecdote on caregivers\u2019 willingness to use corticosteroids: a randomized controlled trial [formula: see text]. J Cutan Med Surg. 2020;24:17\u201322.","journal-title":"J Cutan Med Surg"},{"key":"781_CR9","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1111\/bjd.17757","volume":"181","author":"MC Johnson","year":"2019","unstructured":"Johnson MC, Oussedik E, Joshi K, Feldman SR. Engagement can increase patient willingness to take medications. Br J Dermatol. 2019;181:408\u20139.","journal-title":"Br J Dermatol"},{"key":"781_CR10","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1007\/s13555-021-00542-8","volume":"11","author":"ML Hrin","year":"2021","unstructured":"Hrin ML, Feldman SR. Confidence in biosimilar drugs is not much improved by framing them as the \u201cgold\u201d alternative treatment option to bio-originators. Dermatol Ther (Heidelb). 2021;11:1409\u201313.","journal-title":"Dermatol Ther (Heidelb)"},{"key":"781_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0226394","volume":"14","author":"J Robinson","year":"2019","unstructured":"Robinson J, Rosenzweig C, Moss AJ, Litman L. Tapped out or barely tapped? Recommendations for how to harness the vast and largely unused potential of the Mechanical Turk participant pool. PLoS ONE. 2019;14: e0226394.","journal-title":"PLoS ONE"},{"key":"781_CR12","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.3389\/fpsyg.2017.01359","volume":"8","author":"MG Keith","year":"2017","unstructured":"Keith MG, Tay L, Harms PD. Systems perspective of amazon mechanical turk for organizational research: review and recommendations. Front Psychol. 2017;8:1359.","journal-title":"Front Psychol"},{"key":"781_CR13","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1177\/2167702612469015","volume":"1","author":"DN Shapiro","year":"2013","unstructured":"Shapiro DN, Chandler J, Mueller PA. Using Mechanical Turk to study clinical populations. Clin Psychol Sci. 2013;1:213\u201320.","journal-title":"Clin Psychol Sci"},{"key":"781_CR14","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s11606-017-4246-0","volume":"33","author":"K Mortensen","year":"2018","unstructured":"Mortensen K, Hughes TL. Comparing Amazon\u2019s Mechanical Turk platform to conventional data collection methods in the health and medical research literature. J Gen Intern Med. 2018;33:533\u20138.","journal-title":"J Gen Intern Med"}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-022-00781-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-022-00781-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-022-00781-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,10]],"date-time":"2022-09-10T04:34:41Z","timestamp":1662784481000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13555-022-00781-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,28]]},"references-count":14,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["781"],"URL":"https:\/\/doi.org\/10.1007\/s13555-022-00781-3","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"type":"print","value":"2193-8210"},{"type":"electronic","value":"2190-9172"}],"subject":[],"published":{"date-parts":[[2022,7,28]]},"assertion":[{"value":"31 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}